Clinical News and Research

RSS

Study Finds Methylated CD Derivatives as Effective Stabilizers for Supersaturated Drugs

In the medicine market, most newly introduced drugs and drug candidates show poor water solubility, which prevents their absorption in the body. This, in turn, limits their therapeutic efficiency.

16 May 2023

Heat-Loving Marine Bacteria can Help Reduce Asbestos' Toxicity

Asbestos materials were once widely used in homes, buildings, automobile brakes and many other built materials due to their strength and resistance to heat and fire, as well as to their low electrical conductivity.

16 May 2023

First Humanized Mouse Model for Congenital Adrenal Hyperplasia Developed

Mice with a defected human gene responsible for a rare genetic disease, called congenital adrenal hyperplasia, have been developed for the first time.

16 May 2023

Targeting Respiratory Viral Infections with a New Immunotherapy Treatment

A researcher at the University of Central Florida College of Medicine has created a novel, more effective therapy for acute respiratory viral infections, a significant global cause of illness each year.

16 May 2023

Fecal Microbiota Transplantation to Help in Clostridioides difficile Infection

In Europe, Clostridioides difficile infection results in severe diarrhea and leads to the death of around 20,000 patients, every year. It is one of the most common hospital-acquired infections.

16 May 2023

NIH Common Fund Selects New York Genome Center as Multi-Grant Recipient Under SMaHT Network

The National Institutes of Health (NIH) Common Fund has selected the New York Genome Center (NYGC) as a multi-grant recipient under the Somatic Mosaicism across Human Tissues (SMaHT) Network.

15 May 2023

New Insights Into How Diverse Chromosomal Alterations Form and Drive Cancer Development

The goal of every dividing cell is to accurately segregate its genome into two genetically identical daughter cells.

12 May 2023

Chemical Modification Improves Non-Viral Gene Editing as Well as a New Type of DNA Repair

Gene editing is a powerful method for both research and therapy. Since the advent of the Nobel Prize-winning CRISPR/Cas9 technology, a quick and accurate tool for genome editing discovered in 2012, scientists have been working to explore its capabilities and boost its performance.

12 May 2023

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Discussions of cancer often stress the genetic mutations that drive disease by altering the normal function of cellular proteins.

12 May 2023

Prime Editing System Could Accelerate the Study of Cancer-Linked Mutations

Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development.

12 May 2023

Mitochondria Transfer From Astrocytes Enhances Tumorigenesis in Glioblastoma

Glioblastoma cancer cells use mitochondria from the central nervous system to grow and form more aggressive tumors, according to new Cleveland Clinic-led findings published in Nature Cancer.

12 May 2023

Researchers Use Cheese Rinds to Show Fungal Antibiotics Can Influence Microbiome Development

Fungi produce metabolites that humans have used to improve health. For example, they secrete penicillin, which is then purified and used as an antibiotic for humans, leading to the development of many other antibiotics.

11 May 2023

Using Mass-Spectrometry-Based Cancer Proteomics Datasets to Discover Potential Therapeutic Targets

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting."

11 May 2023

Scientists Engineer the First CRISPR-Based Drug Candidate to Directly Target E. Coli

Many people have experienced infections from E. coli, which are primarily seen as inconvenient and unpleasant.

10 May 2023

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges

From Revvity 9 May 2023

Breakthrough "Gene Silencing" Technology Could Revolutionize the Development of DNAzymes

Researchers from the University of California, Irvine have developed a DNA enzyme – or DNAzyme – that can distinguish between two RNA strands inside a cell and cut the disease-associated strand while leaving the healthy strand intact.

9 May 2023

T Cells can Fuel Their Ability to Attack Tumors

When you need a bit of motivation, it often has to come from within. New research suggests cancer-fighting immune cells have found a way to do just that.

9 May 2023

Patient-Derived Organoids can Help Identify Effective Personalized Cancer Therapies

Researchers created organoids from cancer cells to reduce the need for trial and error in identifying effective cancer treatments in one of many cancer studies scheduled for presentation this week at Digestive Disease Week (DDW) 2023.

9 May 2023

Understanding How Interleukin-6 Contributes to Suppress Allergic Asthma and Atopy

The immune system has a biological telecommunications system -; small proteins known as interleukins that send signals among the leukocyte white blood cells to control their defense against infections or nascent cancer.

8 May 2023

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

A new publication in the May issue of Nature Aging by researchers from Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, demonstrates the power of artificial intelligence (AI) to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.

8 May 2023

Clinical News and Research

Study Finds Methylated CD Derivatives as Effective Stabilizers for Supersaturated Drugs

Heat-Loving Marine Bacteria can Help Reduce Asbestos' Toxicity

First Humanized Mouse Model for Congenital Adrenal Hyperplasia Developed

Targeting Respiratory Viral Infections with a New Immunotherapy Treatment

Fecal Microbiota Transplantation to Help in Clostridioides difficile Infection

NIH Common Fund Selects New York Genome Center as Multi-Grant Recipient Under SMaHT Network

New Insights Into How Diverse Chromosomal Alterations Form and Drive Cancer Development

Chemical Modification Improves Non-Viral Gene Editing as Well as a New Type of DNA Repair

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Prime Editing System Could Accelerate the Study of Cancer-Linked Mutations

Mitochondria Transfer From Astrocytes Enhances Tumorigenesis in Glioblastoma

Researchers Use Cheese Rinds to Show Fungal Antibiotics Can Influence Microbiome Development

Using Mass-Spectrometry-Based Cancer Proteomics Datasets to Discover Potential Therapeutic Targets

Scientists Engineer the First CRISPR-Based Drug Candidate to Directly Target E. Coli

Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure

Breakthrough "Gene Silencing" Technology Could Revolutionize the Development of DNAzymes

T Cells can Fuel Their Ability to Attack Tumors

Patient-Derived Organoids can Help Identify Effective Personalized Cancer Therapies

Understanding How Interleukin-6 Contributes to Suppress Allergic Asthma and Atopy

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

Expert Insights: HiMedia Labs on Advancing Nucleic Acid Extraction Across Industries

Quorum Bio: Where Synthetic Biology Meets Sustainable Farming

Diagnostic Biochips: Pioneering Brain Research Tools for the Future

Latest in Genomics